Bureau of Communicable Disease
The mission of the Bureau of Communicable Disease (BCD) is to prevent and control designated communicable diseases and illness in Alabama. BCD consists of the following divisions:
- For healthcare providers who have a patient admitted to ICU and test positive for enterovirus and/or rhinovirus, ADPH requests a specimen be submitted to test for Enterovirus D69 (EV-D68) in Alabama. Patients who test positive for enterovirus need to read Enterovirus D68 Flyer.
- CDC's latest HAN Severe Respiratory Illness Associated with Enterovirus D68 – Multiple States, 2014.
- CDC has notified states of cases of severe respiratory illnesses occurring in children and providers should consider EV-D68 as a possible cause of clusters of severe respiratory illness and report suspected clusters to the Epidemiology Division at 1-800-338-8374.
- If a healthcare provider has a patient who travel to Guinea, Liberia, Sierra Leone, and Nigeria, in the last 3 weeks and has symptoms of fever and severe headache, muscle pain, weakness, diarrhea, vomiting, abdominal pain, lack of appetite, or unusual bleeding, please complete the Ebola Investigation Form and call Epidemiology Division immediately at 1-800-338-8374.
- For more Ebola information please review the ADPH Ebola ALERT message, CDC HAN Ebola Update #4, Ebola Update #3, Ebola Update #2, and Ebola Update #1. If a person does not meet the criteria for testing yet, they should use the Self Monitor Chart. For general public information, see Ebola Fast Fact Flyer.
- The Centers for Disease Control and Prevention (CDC) laboratory is overwhelmed with chikungunya requests and test results may be delayed. The only private lab in the U.S. performing chikungunya testing is Focus Diagnostics. Focus Diagnostics has accounts with most large reference labs (i.e. Quest, LabCorp, Mayo, ARUP) and many local hospitals. In order to receive more timely results, providers can submit their chikungunya test request to a reference laboratory that has an account with Focus Diagnostics.
- If a healthcare provider suspects a patient to have chikungunya with recent travel history (Southern Florida, Caribbean, Africa, Asia, Europe, India, or Pacific Ocean) please review the ADPH Chikungunya Recommendations, including reporting, patient education, specimen collection, shipping, and resources.
- To determine if a patient needs to be tested for MERS-CoV, please review MERS-CoV ALERT and Investigation Form.
- CDC offers free CE for their Clinician Outreach Communication Activity (COCA) Conference Call.
- Review Alabama Morbidity Report
- The Epidemiology Division has launched a new awareness campaign, DETECT, TEST and REPORT Notifiable Diseases to determine Alabama's true disease burden.